Meral Günaldı

898 total citations
56 papers, 639 citations indexed

About

Meral Günaldı is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Meral Günaldı has authored 56 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Molecular Biology and 10 papers in Surgery. Recurrent topics in Meral Günaldı's work include Gastric Cancer Management and Outcomes (6 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Meral Günaldı is often cited by papers focused on Gastric Cancer Management and Outcomes (6 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Meral Günaldı collaborates with scholars based in Türkiye, United States and Russia. Meral Günaldı's co-authors include Yıldız Okuturlar, Çiğdem Usul Afşar, Berna Bozkurt Duman, Hakan Koçoğlu, İsmail Oğuz Kara, Semra Paydaş, Mehmet Karabulut, Berksoy Şahin, Asuman Gedikbaşı and Şeyda Gündüz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Biomedicine & Pharmacotherapy.

In The Last Decade

Meral Günaldı

54 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meral Günaldı Türkiye 17 280 171 110 109 93 56 639
Shiyu Xiao China 15 192 0.7× 219 1.3× 112 1.0× 138 1.3× 214 2.3× 33 846
Shinichi Nakanuma Japan 18 322 1.1× 173 1.0× 83 0.8× 122 1.1× 202 2.2× 93 752
Rebecca J. McClaine United States 13 240 0.9× 159 0.9× 62 0.6× 116 1.1× 135 1.5× 17 558
Seisho Sakai Japan 14 190 0.7× 138 0.8× 55 0.5× 176 1.6× 103 1.1× 45 556
Xinjun Liang China 13 212 0.8× 114 0.7× 86 0.8× 66 0.6× 61 0.7× 46 528
Wen-hua Zhan China 14 234 0.8× 165 1.0× 69 0.6× 179 1.6× 215 2.3× 47 606
Atif Hussein United States 18 311 1.1× 132 0.8× 62 0.6× 221 2.0× 170 1.8× 59 829
Hongyu Zhang China 16 334 1.2× 301 1.8× 213 1.9× 149 1.4× 100 1.1× 42 842
M. Bauer Germany 12 130 0.5× 262 1.5× 106 1.0× 86 0.8× 50 0.5× 31 581
William Nassib William United States 14 339 1.2× 227 1.3× 73 0.7× 267 2.4× 76 0.8× 44 810

Countries citing papers authored by Meral Günaldı

Since Specialization
Citations

This map shows the geographic impact of Meral Günaldı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meral Günaldı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meral Günaldı more than expected).

Fields of papers citing papers by Meral Günaldı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meral Günaldı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meral Günaldı. The network helps show where Meral Günaldı may publish in the future.

Co-authorship network of co-authors of Meral Günaldı

This figure shows the co-authorship network connecting the top 25 collaborators of Meral Günaldı. A scholar is included among the top collaborators of Meral Günaldı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meral Günaldı. Meral Günaldı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erdem, Di̇lek, et al.. (2022). Discoidin domain receptor 1 as a promising biomarker for high-grade gliomas. Journal of Cancer Research and Therapeutics. 19(Suppl 1). S285–S293. 1 indexed citations
2.
Erdem, Di̇lek, et al.. (2019). Evaluation of the Relationship between eNOS and Breast Cancer. DergiPark (Istanbul University). 2 indexed citations
3.
Koçoğlu, Hakan, Deniz Tural, Yıldız Okuturlar, et al.. (2018). Hepatitis B and C rates are significantly increased in certain solid tumors: A large retrospective study. Journal of Cancer Research and Therapeutics. 14(10). 774–774. 13 indexed citations
4.
Okuturlar, Yıldız, Meral Günaldı, Hakan Koçoğlu, et al.. (2018). Serum paraoxonase and arylesterase can be useful markers to predict neoadjuvant chemotherapy requirement in patients with breast cancer. Journal of Cancer Research and Therapeutics. 14(Suppl 2). S362–S367. 12 indexed citations
5.
Koçoğlu, Hakan, Halil Kavgacı, Meral Günaldı, et al.. (2018). The clinical importance of serum galectin-3 levels in breast cancer patients with and without metastasis. Journal of Cancer Research and Therapeutics. 14(10). 583–583. 13 indexed citations
6.
Günaldı, Meral, Nilgün Işıksaçan, Hakan Koçoğlu, et al.. (2018). The value of serum survivin level in early diagnosis of cancer. Journal of Cancer Research and Therapeutics. 14(3). 570–573. 25 indexed citations
7.
Tanrıverdi, Özgür, Serkan Menekşe, Fatih Teker, et al.. (2017). The mean platelet volume may predict the development of isolated bone metastases in patients with breast cancer: a retrospective study of the Young Researchers Committee of the Turkish Oncology Group (TOG).. PubMed. 21(4). 840–850. 20 indexed citations
8.
Günaldı, Meral, Hakan Koçoğlu, Yıldız Okuturlar, et al.. (2016). Heat shock protein 70 is a useful marker for predicting colorectal cancer.. PubMed. 20(6). 1464–70. 16 indexed citations
9.
Günaldı, Meral, et al.. (2016). A new marker for breast cancer diagnosis, human epididymis protein 4: A preliminary study. Molecular and Clinical Oncology. 5(2). 355–360. 30 indexed citations
10.
Karabulut, Mehmet, Meral Günaldı, Çiğdem Usul Afşar, et al.. (2015). Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma. Clinical & Translational Oncology. 18(2). 160–171. 24 indexed citations
11.
Okuturlar, Yıldız, Fahir Özkalemkaş, Beyza Ener, et al.. (2015). Serum galactomannan levels in the diagnosis of invasive aspergillosis. The Korean Journal of Internal Medicine. 30(6). 899–905. 11 indexed citations
12.
Okuturlar, Yıldız, et al.. (2015). Utility of Peripheral Blood Parameters in Predicting Breast Cancer Risk. Asian Pacific Journal of Cancer Prevention. 16(6). 2409–2412. 52 indexed citations
13.
Günaldı, Meral, Çiğdem Usul Afşar, Berna Bozkurt Duman, et al.. (2015). Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws. Oncology Letters. 10(1). 439–442. 12 indexed citations
14.
Kara, İsmail Oğuz, et al.. (2014). A case report of adult Wilms’ tumour. Contemporary Oncology/Współczesna Onkologia. 2014(1). 1–4. 1 indexed citations
15.
Paydaş, Semra, et al.. (2014). Abdominal actinomycosis with multiple myeloma: A case report. Oncology Letters. 8(4). 1876–1878. 3 indexed citations
16.
Günaldı, Meral, et al.. (2013). Carbamazepine and Multiple Myeloma: Possible Interaction. SHILAP Revista de lepidopterología. 30(1). 83–84. 4 indexed citations
17.
Duman, Berna Bozkurt, et al.. (2012). Capecitabine-Induced Hypertriglyceridemia and Hyperglycemia: Two Cases. Pharmacology. 90(3-4). 212–215. 13 indexed citations
18.
Duman, Berna Bozkurt, Meral Günaldı, Çiğdem Usul Afşar, et al.. (2012). Retrospective Analysis of 498 Primary Soft Tissue Sarcomas in a Single Turkish Centre. Asian Pacific Journal of Cancer Prevention. 13(8). 4125–4128. 7 indexed citations
19.
Günaldı, Meral, et al.. (2012). Primary Intracerebral Myeloid Sarcoma. Onkologie. 35(11). 694–697. 6 indexed citations
20.
Duman, Berna Bozkurt, et al.. (2011). Malignant mixed Mullerian tumor of the ovary with two cases and review of the literature. Archives of Gynecology and Obstetrics. 283(6). 1363–1368. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shiyu Xiao Breakdown of academic impact, for papers by Shinichi Nakanuma Breakdown of academic impact, for papers by Rebecca J. McClaine Breakdown of academic impact, for papers by Seisho Sakai Breakdown of academic impact, for papers by Xinjun Liang Breakdown of academic impact, for papers by Wen-hua Zhan Breakdown of academic impact, for papers by Atif Hussein Breakdown of academic impact, for papers by Hongyu Zhang Breakdown of academic impact, for papers by M. Bauer Breakdown of academic impact, for papers by William Nassib William
Rankless by CCL
2026